FindTrial
Sign In

Evaluation of conversational AI in precision oncology

Pilot Evaluation of gSage for Oncology Clinical Decision Support - gS-oncoCDS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103525
Enrollment
500
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C500- Malignant neoplasm of nipple and areola Health Condition 2: C501- Malignant neoplasm of central portion of breast Health Condition 3: C502- Malignant neoplasm of upper-innerquadrant of breast Health Condition 4: C503- Malignant neoplasm of lower-innerquadrant of breast Health Condition 5: C504- Malignant neoplasm of upper-outerquadrant of breast Health Condition 6: C505- Malignant neoplasm of lower-outerquadrant of breast Health Condition 7: C506- Malignant neoplasm of

Interventions

Intervention1: Nil: Nil

Sponsors

GeneSilico India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 99 years with any breast cancer subtype.

Exclusion criteria

Exclusion criteria: Exclusion Pregnant/breastfeeding Serious uncontrolled comorbidities Inadequate documentation Clinicians without routine oncology roles

Design outcomes

Primary

MeasureTime frame
Primary Objective Improve rate of guideline-concordant treatment recommendationsTimepoint: 12 months—

Secondary

MeasureTime frame
Secondary Decision efficiency: time per case Reasoning quality scores Usability survey resultsTimepoint: 12 months—

Countries

India

Contacts

Public ContactDrEsther

GeneSilico India Private Limited

dsengupta@genesilico.ai9831307912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026